Semaglutide Injection : Out-of-specification (impurity)
Recall Summary Semaglutide Injection products are being recalled across Canada due to an impurity that makes them out-of-specification, meaning they don't meet quality standards. This is classified as a Class II recall, indicating a potential health risk. The recall affects semaglutide injection products distributed throughout Canada.
- Product
- Semaglutide Injection
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-08-26
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/f97e50fe-4772-4c9f-b38e-3dde169dc57a